A class of ribosome-targeting antibiotics designed to bind the bacterial ribosome and inhibit protein synthesis, effective against multidrug-resistant Gram-positive and Gram-negative bacteria.

An antibiotic from the OPP class preorganized for ribosomal binding that overcomes antimicrobial resistance in bacterial infections.